AnaptysBio, Inc. (ANAB)
60.41
+0.33
(+0.55%)
USD |
NASDAQ |
May 21, 16:00
60.39
-0.02
(-0.03%)
After-Hours: 19:59
AnaptysBio Research and Development Expense (TTM) : 128.24M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 101.99M |
| TG Therapeutics, Inc. | 162.25M |
| ADMA Biologics, Inc. | 6.532M |
| Mirum Pharmaceuticals, Inc. | 237.68M |
| Rocket Pharmaceuticals, Inc. | 131.80M |